Coping with COVID vaccine concerns

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Dr Linda Calabresi

Vaccine hesitancy is one thing, but a complete crisis of confidence is another. The AstraZeneca COVID vaccine, once touted as our get-out-of-jail-free card is now being viewed with suspicion and trepidation by an increasing number of our patients, according to a recent Healthed survey of GPs.

The survey of over 600 Australian GPs sought to gauge the public’s reaction to the AstraZeneca vaccine, following reports of the rare but headline-grabbing clotting side-effect.

Almost two-thirds of the GPs (64.72%) said they had seen an increase in the number of patients expressing serious concerns with regard the vaccine but would have it anyway. Even more worrying was the 60.53% who had more patients put off the vaccine until a later date because of very serious concerns, and 45.56% who had an increased number of patients refuse the vaccine completely.

And it would seem that even health professionals have some reservations with 64.7% saying, given the choice they would opt for the Pfizer one. However, a decent percentage (28.41%) said they didn’t mind whichever vaccine they were given while only 6.89% reported a preference for the AstraZeneca formulation.

 

If hypothetically, you could choose which vaccine you received, which would you prefer?

In your practice over the past 1-2 months, in what ways have the number of patients in each category changed?

  • Answered: 658
  • Skipped: 206

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Marie-Claire Seeley

Dr Marie-Claire Seeley

Postural Orthostatic Tachycardia Syndrome in Women

Dr Charlotte Hespe & Dr Ramy Bishay

Dr Charlotte Hespe & Dr Ramy Bishay

Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D

Dr Anthony Chitti

Dr Anthony Chitti

Big Heads & Small Heads

Dr Sam Mehr

Dr Sam Mehr

Peanut Allergy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D

Tuesday 17th March, 7pm - 9pm AEDT

Speakers

Dr Charlotte Hespe & Dr Ramy Bishay

General Practitioner & Endocrinologist

Join Dr Charlotte Hespe and Dr Ramy Bishay for this expert panel webcast presentation, where they will discuss the role of GLP-1 in the management of CKD in T2D.